606 related articles for article (PubMed ID: 20518524)
21. RNA interference technology with emphasis on delivery vehicles-prospects and limitations.
Prabha S; Vyas R; Gupta N; Ahmed B; Chandra R; Nimesh S
Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1391-9. PubMed ID: 26140615
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic siRNA: principles, challenges, and strategies.
Gavrilov K; Saltzman WM
Yale J Biol Med; 2012 Jun; 85(2):187-200. PubMed ID: 22737048
[TBL] [Abstract][Full Text] [Related]
23. [Research progress on the development of the strategies for siRNAs delivery in vivo].
Tang D; Mao A
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Aug; 29(4):775-9. PubMed ID: 23016434
[TBL] [Abstract][Full Text] [Related]
24. Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing.
Harborth J; Elbashir SM; Vandenburgh K; Manninga H; Scaringe SA; Weber K; Tuschl T
Antisense Nucleic Acid Drug Dev; 2003 Apr; 13(2):83-105. PubMed ID: 12804036
[TBL] [Abstract][Full Text] [Related]
25. Palmitic acid-conjugated 21-nucleotide siRNA enhances gene-silencing activity.
Kubo T; Yanagihara K; Takei Y; Mihara K; Morita Y; Seyama T
Mol Pharm; 2011 Dec; 8(6):2193-203. PubMed ID: 21985606
[TBL] [Abstract][Full Text] [Related]
26. CXCR4-targeted modular peptide carriers for efficient anti-VEGF siRNA delivery.
Egorova A; Shubina A; Sokolov D; Selkov S; Baranov V; Kiselev A
Int J Pharm; 2016 Dec; 515(1-2):431-440. PubMed ID: 27789364
[TBL] [Abstract][Full Text] [Related]
27. Allele-specific silencing by RNA interference.
Hohjoh H
Methods Mol Biol; 2010; 623():67-79. PubMed ID: 20217544
[TBL] [Abstract][Full Text] [Related]
28. Nanoparticle/siRNA-based therapy strategies in glioma: which nanoparticles, which siRNAs?
Aigner A; Kögel D
Nanomedicine (Lond); 2018 Jan; 13(1):89-103. PubMed ID: 29199893
[TBL] [Abstract][Full Text] [Related]
29. Effect of north bicyclo[3.1.0]hexane 2'-deoxy-pseudosugars on RNA interference: a novel class of siRNA modification.
Terrazas M; Ocampo SM; Perales JC; Marquez VE; Eritja R
Chembiochem; 2011 May; 12(7):1056-65. PubMed ID: 21452187
[TBL] [Abstract][Full Text] [Related]
30. Rational siRNA design for RNA interference.
Reynolds A; Leake D; Boese Q; Scaringe S; Marshall WS; Khvorova A
Nat Biotechnol; 2004 Mar; 22(3):326-30. PubMed ID: 14758366
[TBL] [Abstract][Full Text] [Related]
31. Designing siRNA and Evaluating Its Effect on RNA Targets Using qPCR and Western Blot.
Vidarsdottir L; Goroshchuk O; Kolosenko I; Palm-Apergi C
Methods Mol Biol; 2019; 2036():53-72. PubMed ID: 31410790
[TBL] [Abstract][Full Text] [Related]
32. Delivery materials for siRNA therapeutics.
Kanasty R; Dorkin JR; Vegas A; Anderson D
Nat Mater; 2013 Nov; 12(11):967-77. PubMed ID: 24150415
[TBL] [Abstract][Full Text] [Related]
33. Multifunctional nanocarrier based on clay nanotubes for efficient intracellular siRNA delivery and gene silencing.
Wu H; Shi Y; Huang C; Zhang Y; Wu J; Shen H; Jia N
J Biomater Appl; 2014 Apr; 28(8):1180-9. PubMed ID: 23985535
[TBL] [Abstract][Full Text] [Related]
34. Confocal microscopy for the analysis of siRNA delivery by polymeric nanoparticles.
Portis AM; Carballo G; Baker GL; Chan C; Walton SP
Microsc Res Tech; 2010 Sep; 73(9):878-85. PubMed ID: 20803695
[TBL] [Abstract][Full Text] [Related]
35. [New progress of the highly efficient siRNA design].
Xu DH; Huang C; Liu LY; Song TS
Yi Chuan; 2006 Nov; 28(11):1457-61. PubMed ID: 17098718
[TBL] [Abstract][Full Text] [Related]
36. Magnetic nanoparticle and magnetic field assisted siRNA delivery in vitro.
Mykhaylyk O; Sanchez-Antequera Y; Vlaskou D; Cerda MB; Bokharaei M; Hammerschmid E; Anton M; Plank C
Methods Mol Biol; 2015; 1218():53-106. PubMed ID: 25319646
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of Gold Nanoparticles for Gene Silencing.
Tortiglione C; de la Fuente JM
Methods Mol Biol; 2019; 1974():203-214. PubMed ID: 31099005
[TBL] [Abstract][Full Text] [Related]
38. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
Aigner A
J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
[TBL] [Abstract][Full Text] [Related]
39. Small Interfering RNAs and their Delivery Systems: A Novel Powerful Tool for the Potential Treatment of HIV Infections.
Bolhassani A; Milani A
Curr Mol Pharmacol; 2020; 13(3):173-181. PubMed ID: 31760929
[TBL] [Abstract][Full Text] [Related]
40. Synergistic silencing: combinations of lipid-like materials for efficacious siRNA delivery.
Whitehead KA; Sahay G; Li GZ; Love KT; Alabi CA; Ma M; Zurenko C; Querbes W; Langer RS; Anderson DG
Mol Ther; 2011 Sep; 19(9):1688-94. PubMed ID: 21750531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
